MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2023 International Congress

    Movement disorders in the setting of dengue infection in a rural medical teaching hospital in Gujarat, India

    D. Desai, S. Desai (Anand, India)

    Objective: To determine the frequency and types of movement disorders in patients with dengue. Background: Dengue fever is a common viral infection presenting with fever,…
  • 2023 International Congress

    A Retrospective Review of Amantadine in Progressive Supranuclear Palsy

    N. Mcfarland, R. Farrukh, S. Mahn (Gainesville, USA)

    Objective: To determine the efficacy and tolerability of amantadine in Progressive supranuclear palsy (PSP). Background: PSP is one of the most common atypical parkinsonian disorders,…
  • 2023 International Congress

    Video-Based Motor Function Assessment by Professional Raters or by Software in Patients with Parkinson’s Disease

    WX. Wu, GJ. Jing, XX. Xu, LZZ. Li, YF. Yang, GXD. Guo (Shanghai, China)

    Objective: To evaluate the consistency of objective movement variables between a computer vision-based movement dysfunction assessment software (MoDAS) and professional raters in video-based motor function…
  • 2023 International Congress

    Clinical characteristics of patients with dementia with Lewy bodies followed in a movement disorder clinic

    AS. Jakobsson, L. Salvesen, AM. Hejl (Copenhagen, Denmark)

    Objective: To describe the clinical phenotype of the subgroup of patients with Dementia with Lewy bodies (DLB) followed in a movement disorder setting rather than…
  • 2023 International Congress

    Ethical considerations in person-centered Parkinson’s disease care: a cross-national comparison of patients’ perspectives

    J. Stuempel, M. van Munster, B. Schmitz-Luhn, T. Mestre, C. Woopen (Bonn, Germany)

    Objective: To identify which ethical requirements are placed by people with Parkinson’s disease (PwPDs) and their care partners on person-centered care. Background: To improve the…
  • 2023 International Congress

    Rapidly progressive dementia – catatonia – myoclonus in 80 years old patient: An unusual case

    DAN. Rebolledo Garcia, ART. Cadena Fernandez, ANA. Michel Chavez, JUA. Calderon Martinez, HOR. Senties Madrid, GRI. Romero Sanchez (Mexico City, Mexico)

    Objective: Objective:Sporadic Creutzfeldt-Jakob Disease (sCJD) will be challenging to differentiate from other diseases, like NMDA autoimmune encephalitis (AE). The classic rapidly progressive dementia phenotype that…
  • 2022 International Congress

    X-Linked Dystonia Parkinsonism as the cause of Isolated Lingual Dystonia (ILD)

    D. Dakay, G. Saranza, Z. Leonardo, C. Klein, N. Brüggemann, A. Westenberger (Mandaue City, Philippines)

    Objective: This report aims to describe a 43-year-old Filipino male with ILD aggravated by speech and swallowing. This paper highlights the importance of including XDP…
  • 2022 International Congress

    Autonomic Nervous System Dysfunction in idiopathic REM sleep behaviour disorder

    Y. Shao, T. Wijratne (Melbourne, Australia)

    Objective: To characterise autonomic impairment in REM sleep behaviour disorders, and to investigate the pathophysiological link between autonomic impairment and REM sleep behaviour disorder Background:…
  • 2022 International Congress

    Conservative iron chelation for Neuroferritinopathy

    F. Marchand, C. Moreau, G. Kuchcinski, V. Huin, L. Defebvre, D. Devos (LILLE, France)

    Objective: Evaluate the safety and efficacy of a conservative mode of iron chelation with deferiprone 30 mg/kg/day in neuroferritinopathy to limit iron-related neurodegeneration and associated…
  • 2022 International Congress

    Clinical Manifestations of Autonomic Dysfunction in Parkinsonism Assessed by COMPASS-31 Questionnaire

    D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: The study aims to describe the manifestations of autonomic disorders, including symptoms and related factors, in Parkinsonism cases ​​​​​​​ Background: Parkinsonism is a progressive neurodegenerative…
  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley